Thread by @NikoLusiani, A year in, 1 in 4 people in rich countries like the [...]

Niko Lusiani

NikoLusiani

A year in, 1 in 4 people in rich countries like the US have gotten a COVID vaccine.

In poorer countries? Just 1 in 500.

I’m repping @OxfamAmerica to call for a #PeoplesVaccine at @Pfizer’s annual shareholder meeting. #AskTheCEO:
THREAD 1/

A quick rundown: Taxpayers like you & me invested billions in the #COVID19 vaccines, eg creating a market for @Pfizer.

Scientists then collaborated to bring the world vaccines in record time.

Covid vaccines shouldn't 'belong' to any one company, they belong to all of us. 2/

. @Pfizer and @BioNTech_Group are in a position to save millions of lives and end the pandemic by making their vaccine a public good.
@Oxfam 's new research shows Pfizer has only allocated around 15% of its vaccine to poorer countries. 3/

What’s more, @Pfizer and others are preventing widespread and scaled-up supply of the vaccine by not supporting for the WHO’s Coronavirus Technology Access Pool (C-TAP) and proposed mRNA technology transfer hub. #JoinCTAP 4/

We’re living in a moment of great historical significance, which as @AmbassadorTai rightly said, demands sacrifice.

So, here is my question to @Pfizer CEO today at the company's virtual shareholder meeting:

5/

Under what circumstances would @Pfizer #JoinCTAP & contribute to the @WHO s mRNA tech transfer hub to stimulate additional qualified manufacturers around the world to innovate - free of intellectual property constraints- & produce many more, low-cost vaccines for us all? 6/

We’re all in this together. Let’s show it.

Stay tuned to see how @Pfizer responds.
#AsktheCEO #JoinCTAP 7/

THIS JUST IN: @Pfizer CEO did NOT commit to join @WHO s C-TAP, defending IP protections & focusing on expanding its own production not tech transfer. 8/

Meanwhile, almost 1/3 of @Pfizer shareholders (29.9%) vote to demand more info on how public $ for the vaccine affects global access. 9/

More info on this: https://www.fiercepharma.com/pharma/shareholders-to-push-for-detailed-covid-19-pricing-strategies-from-pfizer-j-j-and-merck-at

Shareholders to push for detailed COVID-19 pricing strategies from Pfizer, J&J at annual meetings

The Interfaith Center on Corporate Responsibility submitted shareholder proposals requesting Johnson & Johnson, Pfizer and Merck provide greater detail on how they plan to develop access and pricing...

https://www.fiercepharma.com/pharma/shareholders-to-push-for-detailed-covid-19-pricing-strategies-from-pfizer-j-j-and-merck-at

You can follow @NikoLusiani.

Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled: